An2 Therapeutics Stock Price History

ANTX Stock  USD 1.46  0.05  3.55%   
If you're considering investing in AN2 Stock, it is important to understand the factors that can impact its price. As of today, the current price of AN2 Therapeutics stands at 1.46, as last reported on the 19th of March, with the highest price reaching 1.47 and the lowest price hitting 1.40 during the day. AN2 Therapeutics appears to be very risky, given 3 months investment horizon. AN2 Therapeutics retains Efficiency (Sharpe Ratio) of 0.071, which signifies that the company had a 0.071 % return per unit of price deviation over the last 3 months. We have found twenty-three technical indicators for AN2 Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of AN2 Therapeutics' Market Risk Adjusted Performance of (0.11), information ratio of 0.0102, and Variance of 10.17 to double-check if our risk estimates are consistent with your expectations.
  
At this time, AN2 Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 167.5 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 21.8 M in 2025. . Price Earnings Ratio is likely to drop to -7.06 in 2025. Price Book Value Ratio is likely to drop to 4.24 in 2025. AN2 Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.071

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsANTX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.12
  actual daily
27
73% of assets are more volatile

Expected Return

 0.22
  actual daily
4
96% of assets have higher returns

Risk-Adjusted Return

 0.07
  actual daily
5
95% of assets perform better
Based on monthly moving average AN2 Therapeutics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AN2 Therapeutics by adding it to a well-diversified portfolio.
Price Book
0.4805
Book Value
2.935
Enterprise Value
-53.1 M
Enterprise Value Ebitda
(2.11)
Shares Float
17.5 M

AN2 Therapeutics Stock Price History Chart

There are several ways to analyze AN2 Stock price data. The simplest method is using a basic AN2 candlestick price chart, which shows AN2 Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceMarch 19, 20251.46
Lowest PriceFebruary 13, 20251.07

AN2 Therapeutics March 19, 2025 Stock Price Synopsis

Various analyses of AN2 Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell AN2 Stock. It can be used to describe the percentage change in the price of AN2 Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of AN2 Stock.
AN2 Therapeutics Price Daily Balance Of Power 0.71 
AN2 Therapeutics Price Action Indicator 0.05 
AN2 Therapeutics Price Rate Of Daily Change 1.04 
AN2 Therapeutics Accumulation Distribution 2,363 

AN2 Therapeutics March 19, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in AN2 Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use AN2 Therapeutics intraday prices and daily technical indicators to check the level of noise trading in AN2 Stock and then apply it to test your longer-term investment strategies against AN2.

AN2 Stock Price History Data

The price series of AN2 Therapeutics for the period between Thu, Dec 19, 2024 and Wed, Mar 19, 2025 has a statistical range of 0.48 with a coefficient of variation of 9.76. The prices are distributed with arithmetic mean of 1.26. The median price for the last 90 days is 1.26. The company issued dividends on 2018-01-11.
OpenHighLowCloseVolume
03/19/2025 1.40  1.47  1.40  1.46  49,624 
03/18/2025 1.37  1.41  1.37  1.41  28,800 
03/17/2025 1.40  1.41  1.38  1.39  36,407 
03/14/2025 1.43  1.43  1.39  1.40  39,864 
03/13/2025 1.35  1.43  1.34  1.41  123,110 
03/12/2025 1.35  1.37  1.34  1.35  60,408 
03/11/2025 1.35  1.39  1.31  1.36  120,247 
03/10/2025 1.30  1.37  1.30  1.35  175,032 
03/07/2025 1.29  1.32  1.29  1.31  56,623 
03/06/2025 1.25  1.32  1.25  1.29  147,609 
03/05/2025 1.14  1.26  1.13  1.25  256,170 
03/04/2025 1.10  1.16  1.09  1.15  449,163 
03/03/2025 1.14  1.16  1.10  1.12  178,642 
02/28/2025 1.12  1.14  1.09  1.14  57,118 
02/27/2025 1.13  1.13  1.11  1.11  61,527 
02/26/2025 1.13  1.15  1.11  1.13  251,006 
02/25/2025 1.13  1.14  1.09  1.11  123,182 
02/24/2025 1.13  1.19  1.12  1.14  144,251 
02/21/2025 1.12  1.15  1.12  1.13  342,633 
02/20/2025 1.14  1.16  1.13  1.13  107,215 
02/19/2025 1.17  1.17  1.09  1.15  116,231 
02/18/2025 1.11  1.20  1.11  1.14  219,576 
02/14/2025 1.10  1.12  1.08  1.12  138,913 
02/13/2025 1.08  1.11  1.05  1.07  256,591 
02/12/2025 1.11  1.14  1.07  1.09  203,090 
02/11/2025 1.12  1.14  1.11  1.11  224,874 
02/10/2025 1.09  1.14  1.09  1.14  170,613 
02/07/2025 1.10  1.13  1.06  1.08  41,242 
02/06/2025 1.17  1.17  1.10  1.10  139,769 
02/05/2025 1.11  1.17  1.09  1.17  196,785 
02/04/2025 1.12  1.14  1.10  1.11  43,879 
02/03/2025 1.11  1.12  1.09  1.09  158,913 
01/31/2025 1.17  1.19  1.12  1.14  112,650 
01/30/2025 1.18  1.19  1.16  1.17  73,635 
01/29/2025 1.24  1.24  1.16  1.18  152,395 
01/28/2025 1.27  1.27  1.21  1.23  117,593 
01/27/2025 1.26  1.26  1.25  1.26  31,502 
01/24/2025 1.26  1.26  1.24  1.25  147,589 
01/23/2025 1.26  1.28  1.24  1.25  227,765 
01/22/2025 1.29  1.29  1.23  1.26  156,675 
01/21/2025 1.29  1.29  1.25  1.27  107,206 
01/17/2025 1.29  1.29  1.26  1.27  89,777 
01/16/2025 1.27  1.27  1.24  1.27  56,410 
01/15/2025 1.22  1.26  1.22  1.25  83,337 
01/14/2025 1.27  1.28  1.22  1.22  83,490 
01/13/2025 1.24  1.28  1.23  1.26  170,888 
01/10/2025 1.29  1.29  1.24  1.25  179,457 
01/08/2025 1.34  1.37  1.29  1.30  81,995 
01/07/2025 1.39  1.40  1.35  1.35  63,646 
01/06/2025 1.44  1.44  1.38  1.38  95,617 
01/03/2025 1.34  1.44  1.34  1.42  192,725 
01/02/2025 1.39  1.44  1.36  1.39  182,674 
12/31/2024 1.40  1.42  1.32  1.38  159,467 
12/30/2024 1.42  1.43  1.40  1.41  68,828 
12/27/2024 1.39  1.45  1.39  1.44  154,709 
12/26/2024 1.34  1.41  1.34  1.38  100,280 
12/24/2024 1.42  1.42  1.34  1.36  122,288 
12/23/2024 1.27  1.43  1.26  1.40  512,625 
12/20/2024 1.25  1.28  1.24  1.26  113,249 
12/19/2024 1.31  1.32  1.23  1.27  228,500 
12/18/2024 1.34  1.37  1.31  1.31  133,216 

About AN2 Therapeutics Stock history

AN2 Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for AN2 is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AN2 Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing AN2 Therapeutics stock prices may prove useful in developing a viable investing in AN2 Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding27.1 M21.8 M
Net Loss-38.5 M-40.4 M

AN2 Therapeutics Quarterly Net Working Capital

87.67 Million

AN2 Therapeutics Stock Technical Analysis

AN2 Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of AN2 Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of AN2 Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module

AN2 Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for AN2 Therapeutics' price direction in advance. Along with the technical and fundamental analysis of AN2 Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of AN2 to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for AN2 Stock Analysis

When running AN2 Therapeutics' price analysis, check to measure AN2 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AN2 Therapeutics is operating at the current time. Most of AN2 Therapeutics' value examination focuses on studying past and present price action to predict the probability of AN2 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AN2 Therapeutics' price. Additionally, you may evaluate how the addition of AN2 Therapeutics to your portfolios can decrease your overall portfolio volatility.